Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Padlock Therapeutics gets $23mm through Series A to fund PAD enzyme research

Executive Summary

Padlock Therapeutics Inc., a newly formed company developing autoimmune disease treatments, raised $23mm through its Series A round. Co-founder Atlas Venture led and was joined by Index Ventures, J&J Development Corp., and MS Ventures.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register